BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21858082)

  • 21. Stress-induced and ATF7-dependent epigenetic change influences cellular senescence.
    Maekawa T; Liu B; Liu Y; Yoshida K; Muratani M; Chatton B; Ishii S
    Genes Cells; 2019 Sep; 24(9):627-635. PubMed ID: 31294895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair.
    Hayakawa J; Depatie C; Ohmichi M; Mercola D
    J Biol Chem; 2003 Jun; 278(23):20582-92. PubMed ID: 12663670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The kinetic mechanism of the dual phosphorylation of the ATF2 transcription factor by p38 mitogen-activated protein (MAP) kinase alpha. Implications for signal/response profiles of MAP kinase pathways.
    Waas WF; Lo HH; Dalby KN
    J Biol Chem; 2001 Feb; 276(8):5676-84. PubMed ID: 11069918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the transcriptional repressor ATF3 in gonadotrophs is regulated by Egr-1, CREB, and ATF2 after gonadotropin-releasing hormone receptor stimulation.
    Mayer SI; Dexheimer V; Nishida E; Kitajima S; Thiel G
    Endocrinology; 2008 Dec; 149(12):6311-25. PubMed ID: 18719024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient receptor potential melastatin-3 (TRPM3)-induced activation of AP-1 requires Ca2+ ions and the transcription factors c-Jun, ATF2, and ternary complex factor.
    Lesch A; Hui X; Lipp P; Thiel G
    Mol Pharmacol; 2015 Apr; 87(4):617-28. PubMed ID: 25576487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation and interaction of ATF2 with the coactivator ASC-2 are responsive for granulocytic differentiation by retinoic acid.
    Hong S; Choi HM; Park MJ; Kim YH; Choi YH; Kim HH; Choi YH; Cheong J
    J Biol Chem; 2004 Apr; 279(17):16996-7003. PubMed ID: 14734562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. JNK-mediated activation of ATF2 contributes to dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease.
    Huang Q; Du X; He X; Yu Q; Hu K; Breitwieser W; Shen Q; Ma S; Li M
    Exp Neurol; 2016 Mar; 277():296-304. PubMed ID: 26515688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A.
    Duyndam MC; van Dam H; Smits PH; Verlaan M; van der Eb AJ; Zantema A
    Oncogene; 1999 Apr; 18(14):2311-21. PubMed ID: 10327051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A functional interaction between ATF7 and TAF12 that is modulated by TAF4.
    Hamard PJ; Dalbies-Tran R; Hauss C; Davidson I; Kedinger C; Chatton B
    Oncogene; 2005 May; 24(21):3472-83. PubMed ID: 15735663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The transcription factor ATF7 mediates lipopolysaccharide-induced epigenetic changes in macrophages involved in innate immunological memory.
    Yoshida K; Maekawa T; Zhu Y; Renard-Guillet C; Chatton B; Inoue K; Uchiyama T; Ishibashi K; Yamada T; Ohno N; Shirahige K; Okada-Hatakeyama M; Ishii S
    Nat Immunol; 2015 Oct; 16(10):1034-43. PubMed ID: 26322480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of melanoma growth by small molecules that promote the mitochondrial localization of ATF2.
    Varsano T; Lau E; Feng Y; Garrido M; Milan L; Heynen-Genel S; Hassig CA; Ronai ZA
    Clin Cancer Res; 2013 May; 19(10):2710-22. PubMed ID: 23589174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATF7 mediates TNF-α-induced telomere shortening.
    Maekawa T; Liu B; Nakai D; Yoshida K; Nakamura KI; Yasukawa M; Koike M; Takubo K; Chatton B; Ishikawa F; Masutomi K; Ishii S
    Nucleic Acids Res; 2018 May; 46(9):4487-4504. PubMed ID: 29490055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells.
    Kim ES; Sohn YW; Moon A
    Cancer Lett; 2007 Jul; 252(1):147-56. PubMed ID: 17258390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TIP49b, a regulator of activating transcription factor 2 response to stress and DNA damage.
    Cho SG; Bhoumik A; Broday L; Ivanov V; Rosenstein B; Ronai Z
    Mol Cell Biol; 2001 Dec; 21(24):8398-413. PubMed ID: 11713276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAB1beta (transforming growth factor-beta-activated protein kinase 1-binding protein 1beta ), a novel splicing variant of TAB1 that interacts with p38alpha but not TAK1.
    Ge B; Xiong X; Jing Q; Mosley JL; Filose A; Bian D; Huang S; Han J
    J Biol Chem; 2003 Jan; 278(4):2286-93. PubMed ID: 12429732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective interaction of JNK protein kinase isoforms with transcription factors.
    Gupta S; Barrett T; Whitmarsh AJ; Cavanagh J; Sluss HK; Dérijard B; Davis RJ
    EMBO J; 1996 Jun; 15(11):2760-70. PubMed ID: 8654373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATF7-dependent epigenetic changes induced by high temperature during early porcine embryonic development.
    Sun MH; Jiang WJ; Li XH; Lee SH; Heo G; Zhou D; Choi JS; Kim KS; Lv W; Cui XS
    Cell Prolif; 2023 Feb; 56(2):e13352. PubMed ID: 36254813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JNK suppresses tumor formation via a gene-expression program mediated by ATF2.
    Gozdecka M; Lyons S; Kondo S; Taylor J; Li Y; Walczynski J; Thiel G; Breitwieser W; Jones N
    Cell Rep; 2014 Nov; 9(4):1361-74. PubMed ID: 25456131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of gene transcription by a constitutively active mutant of activating transcription factor 2 (ATF2).
    Steinmüller L; Thiel G
    Biol Chem; 2003 Apr; 384(4):667-72. PubMed ID: 12751796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ATF7-Dependent Epigenetic Changes Are Required for the Intergenerational Effect of a Paternal Low-Protein Diet.
    Yoshida K; Maekawa T; Ly NH; Fujita SI; Muratani M; Ando M; Katou Y; Araki H; Miura F; Shirahige K; Okada M; Ito T; Chatton B; Ishii S
    Mol Cell; 2020 May; 78(3):445-458.e6. PubMed ID: 32197065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.